Common Contracts
389 similar Underwriting Agreement contracts by Natera, Inc., IsoPlexis Corp, IVERIC Bio, Inc., others
2,472,581 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) PRE-FUNDED WARRANTS TO PURCHASE 18,577,419 SHARES OF COMMON STOCK TScan Therapeutics, Inc. UNDERWRITING AGREEMENT April 16, 2024Underwriting Agreement • April 17th, 2024 • TScan Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Shares LOAR HOLDINGS INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • April 17th, 2024 • Loar Holdings, LLC • Aircraft parts & auxiliary equipment, nec • New York
AUNA S.A. Class A Ordinary Shares, with a nominal value of US$0.01 per Share UNDERWRITING AGREEMENTUnderwriting Agreement • January 25th, 2024 • Auna S.A. • Services-offices & clinics of doctors of medicine • New York
•] Shares CG ONCOLOGY, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • January 18th, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • New York
4,550,000 Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 7th, 2023 • Natera, Inc. • Services-medical laboratories • New York
Natera, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives,” “you,” “your”), an aggregate of 4,550,000 shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 682,500 shares of its common stock, par value $0.0001 per share (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are herein
20,000,000 Shares ALLOVIR, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 26th, 2023 • Allovir, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned understands that J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BofA Securities, Inc. propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with AlloVir, Inc., a Delaware corporation (the “Company”), as representatives (the “Representatives”) of the several underwriters listed in Schedule I to the Underwriting Agreement (the “Underwriters”), providing for the public offering (the “Public Offering”) by the several Underwriters of shares (the “Shares”) of the common stock, par value $0.0001 per share, of the Company (the “Common Stock”).
12,500,000 Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2023 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
11,032,656 Shares ZENTALIS PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2023 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Morgan Stanley & Co. LLC Jefferies LLC SVB Securities LLC c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 c/o Jefferies LLC 520 Madison Avenue New York, New York 10022 c/o SVB Securities LLC 1301 Avenue of the Americas, 12th Floor New York, New York 10019
] Shares ACELYRIN, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • May 1st, 2023 • ACELYRIN, Inc. • Pharmaceutical preparations • New York
13,350,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 5th, 2022 • IVERIC Bio, Inc. • Pharmaceutical preparations • New York
11,430,000 Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 16th, 2022 • Natera, Inc. • Services-medical laboratories • New York
Natera, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives,” “you,” “your”), an aggregate of 11,430,000 shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 1,714,500 shares of its common stock, par value $0.0001 per share (the “Additional Shares”) if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are here
•] Shares ACRIVON THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 3rd, 2022 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • New York
10,330,000 Shares ZENTALIS PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • May 16th, 2022 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o Jefferies LLC 520 Madison Avenue New York, NY 10022 c/o SVB Securities LLC 1301 Avenue of the Americas, 12th Floor New York, NY 10019
•] Shares SAMSARA INC. CLASS A COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 6th, 2021 • Samsara Inc. • Services-computer integrated systems design • New York
•] Shares HASHICORP, INC. CLASS A COMMON STOCK (PAR VALUE $0.000015 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • November 29th, 2021 • HashiCorp, Inc. • Services-computer programming services • New York
•] Shares IO Biotech, Inc. COMMON STOCK (PAR VALUE [•]) UNDERWRITING AGREEMENTUnderwriting Agreement • November 1st, 2021 • IO Biotech, Inc. • Pharmaceutical preparations • New York
•] Shares Rivian Automotive, Inc. Class A Common Stock, Par Value $0.001 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • November 1st, 2021 • Rivian Automotive, Inc. / DE • Motor vehicles & passenger car bodies • New York
l ] Shares NERDWALLET, INC. CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2021 • Nerdwallet, Inc. • Services-computer processing & data preparation • New York
9,000,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 25th, 2021 • IVERIC Bio, Inc. • Pharmaceutical preparations • New York
•] Shares UDEMY, INC. COMMON STOCK ($0.00001 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 20th, 2021 • Udemy, Inc. • Services-educational services • New York
●] Shares FLUENCE ENERGY, INC. CLASS A COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 19th, 2021 • Fluence Energy, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
The undersigned understands that J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, (the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Fluence Energy, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares of the Class A common stock, par value $0.00001 per share, of the Company (the “Class A Shares”). As used herein, the term “Common Stock” refers to shares of the Company’s common stock, including any shares of Class A Shares.
8,333,000 Shares ISOPLEXIS CORPORATION COMMON STOCK, PAR VALUE $0.001 UNDERWRITING AGREEMENTUnderwriting Agreement • October 13th, 2021 • IsoPlexis Corp • Laboratory analytical instruments • New York
•] Shares iFIT Health & Fitness Inc CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 27th, 2021 • iFit Health & Fitness Inc • Sporting & athletic goods, nec • New York
●] Shares ISOPLEXIS CORPORATION COMMON STOCK, PAR VALUE $0.001 UNDERWRITING AGREEMENTUnderwriting Agreement • September 23rd, 2021 • IsoPlexis Corp • Laboratory analytical instruments • New York
●] Shares FRESHWORKS INC. CLASS A COMMON STOCK, $0.00001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 13th, 2021 • Freshworks Inc. • Services-prepackaged software • New York
Morgan Stanley & Co. LLCJ.P. Morgan Securities LLCBofA Securities, Inc. As representatives of the several Underwriters named in Schedule I to the Underwriting Agreement c/o Morgan Stanley & Co. LLC1585 BroadwayNew York, New York 10036 c/o J.P. Morgan Securities LLC383 Madison AvenueNew York, New York 10179 c/o BofA Securities, Inc.One Bryant ParkNew York, New York 10036
Shares FORGEROCK, INC. CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 7th, 2021 • ForgeRock, Inc. • Services-prepackaged software • New York
●] Shares EVERSIDE HEALTH GROUP, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 27th, 2021 • Everside Health Group, Inc. • Services-health services • New York
•] Shares iCIMS Holding Corp. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 19th, 2021 • iCIMS Holding LLC • Services-prepackaged software • New York
6,600,000 Shares FULCRUM THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2021 • Fulcrum Therapeutics, Inc. • Pharmaceutical preparations • New York
•] Shares ADAGIO THERAPEUTICS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
UNDERWRITING AGREEMENT [•] Shares TENAYA THERAPEUTICS, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHAREUnderwriting Agreement • July 26th, 2021 • Tenaya Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
·] Shares IMMUNEERING CORPORATION COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2021 • Immuneering Corp • Pharmaceutical preparations • New York
12,500,000 Shares INSTRUCTURE HOLDINGS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2021 • Instructure Holdings, Inc. • Services-prepackaged software • New York
4,500,000 Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • July 22nd, 2021 • Natera, Inc. • Services-medical laboratories • New York
Natera, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives,” “you,” “your”), an aggregate of 4,500,000 shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 675,000 shares of its common stock, par value $0.0001 per share (the “Additional Shares”) if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereina
3,926,702 Shares of Common Stock (par value $0.001 per share) AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • July 22nd, 2021 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned understands that H.C. Wainwright & Co., LLC (“H.C. Wainwright”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several underwriters (the “Underwriters”), for whom H.C. Wainwright is acting as the representative of the Underwriters (the “Representative”), of shares (the “Shares”) of the common stock, par value $0.001 per share, of the Company (the “Common Stock”).
